Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2',3'-cyclic nucleotide 3' phosphodiesterase | 0.604 | 0.692 | 0.98 |
|
disease | 0.400 | None | 0.400 | 3 | 0 | 2006 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1991 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 1B | 0.551 | 0.769 | 0.19 |
|
disease | 0.050 | None | 0.600 | 2 | 0 | 2003 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.700 | None | 0.895 | 14 | 0 | 1992 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1995 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 4 | 0.610 | 0.615 | 2.5E-02 |
|
disease | 0.350 | None | 0.250 | 1 | 0 | 2002 | 2013 | ||||||||
|
5-hydroxytryptamine receptor 6 | 0.626 | 0.500 | 1.9E-04 |
|
disease | 0.400 | None | 0.824 | 1 | 0 | 1999 | 2018 | ||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 0.502 | 0.808 | 2.2E-14 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2012 | ||||||||
|
8-oxoguanine DNA glycosylase | 0.453 | 0.808 | 3.9E-12 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2016 | ||||||||
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2006 | 2018 | ||||||||
|
aconitase 2 | 0.619 | 0.654 | 0.21 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 1999 | 2018 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2008 | 2020 | ||||||||
|
acyl-CoA synthetase long chain family member 6 | 0.686 | 0.500 | 3.2E-03 |
|
disease | 0.340 | None | 0.667 | 2 | 0 | 2006 | 2011 | ||||||||
|
adenylate cyclase activating polypeptide 1 | 0.510 | 0.846 | 0.52 |
|
disease | 0.400 | None | 0.750 | 1 | 0 | 2001 | 2019 | ||||||||
|
adenylate kinase 1 | 0.711 | 0.500 | 2.7E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
adenylosuccinate synthase 2 | 0.839 | 0.308 | 0.33 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
disease | 0.330 | None | 1.000 | 2 | 0 | 2004 | 2016 | ||||||||
|
aggrecan | 0.528 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.900 | limited | 0.865 | 4 | 0 | 2001 | 2019 | ||||||||
|
alcohol dehydrogenase 5 (class III), chi polypeptide | 0.604 | 0.731 | 2.5E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
aldolase, fructose-bisphosphate C | 0.780 | 0.231 | 9.2E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2009 | ||||||||
|
amyloid beta precursor protein binding family A member 2 | 0.700 | 0.385 | 0.74 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
ankyrin repeat and kinase domain containing 1 | 0.604 | 0.462 | 7.4E-12 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2007 | 2018 |